The MPTP-treated mouse as a model of parkinsonism: how good is it?
Heikkila
R E
RE
UMDNJ-Robert Wood Johnson Medical School, Department of Neurology, Piscataway 08854.
Sonsalla
P K
PK
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects; D004195:Disease Models, Animal; D005069:Evaluation Studies as Topic; D051379:Mice; D016627:Oxidopamine / Q000494:pharmacology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011323:Primates; D051381:Rats; D012110:Reserpine; D013378:Substantia Nigra / Q000187:drug effects
D012110:Reserpine; D016627:Oxidopamine; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine